Carl A. Merton Purchases 26,000 Shares of Tilray Inc (NASDAQ:TLRY) Stock

Tilray Inc (NASDAQ:TLRY) CFO Carl A. Merton bought 26,000 shares of the stock in a transaction on Friday, November 15th. The stock was purchased at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the purchase, the chief financial officer now owns 26,000 shares of the company’s stock, valued at approximately $35,360. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Tilray Price Performance

Tilray stock opened at $1.31 on Wednesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. Tilray Inc has a one year low of $1.28 and a one year high of $2.97. The firm has a market capitalization of $1.18 billion, a P/E ratio of -4.85 and a beta of 2.14. The business has a fifty day moving average price of $1.64 and a 200-day moving average price of $1.76.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company’s revenue was up 13.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.10) earnings per share. As a group, equities research analysts forecast that Tilray Inc will post -0.14 EPS for the current year.

Analyst Ratings Changes

Separately, Roth Mkm decreased their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.

Hedge Funds Weigh In On Tilray

A number of hedge funds and other institutional investors have recently bought and sold shares of TLRY. Swiss National Bank raised its position in shares of Tilray by 3.6% during the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock valued at $3,683,000 after buying an additional 51,700 shares in the last quarter. Avantax Advisory Services Inc. lifted its stake in Tilray by 46.2% during the first quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock worth $131,000 after purchasing an additional 16,792 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Tilray by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after purchasing an additional 117,891 shares in the last quarter. CreativeOne Wealth LLC bought a new position in shares of Tilray during the 1st quarter valued at about $165,000. Finally, Lazard Asset Management LLC purchased a new position in shares of Tilray during the 1st quarter valued at about $118,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.